Literature DB >> 20920479

Signaling through LRP1: Protection from atherosclerosis and beyond.

Philippe Boucher1, Joachim Herz.   

Abstract

The low-density lipoprotein receptor-related protein (LRP1) is a multifunctional cell surface receptor that belongs to the LDL receptor (LDLR) gene family and that is widely expressed in several tissues. LRP1 consists of an 85-kDa membrane-bound carboxyl fragment (β chain) and a non-covalently attached 515-kDa (α chain) amino-terminal fragment. Through its extracellular domain, LRP1 binds at least 40 different ligands ranging from lipoprotein and protease inhibitor complex to growth factors and extracellular matrix proteins. LRP-1 has also been shown to interact with scaffolding and signaling proteins via its intracellular domain in a phosphorylation-dependent manner and to function as a co-receptor partnering with other cell surface or integral membrane proteins. LRP-1 is thus implicated in two major physiological processes: endocytosis and regulation of signaling pathways, which are both involved in diverse biological roles including lipid metabolism, cell growth/differentiation processes, degradation of proteases, and tissue invasion. The embryonic lethal phenotype obtained after target disruption of the LRP-1 gene in the mouse highlights the biological importance of this receptor and revealed a critical, but yet undefined role in development. Tissue-specific gene deletion studies also reveal an important contribution of LRP1 in vascular remodeling, foam cell biology, the central nervous system, and in the molecular mechanisms of atherosclerosis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20920479      PMCID: PMC2991482          DOI: 10.1016/j.bcp.2010.09.018

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  54 in total

1.  By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation.

Authors:  Shyra J Gardai; Yi-Qun Xiao; Matthew Dickinson; Jerry A Nick; Dennis R Voelker; Kelly E Greene; Peter M Henson
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

2.  Induction of platelet-derived growth factor B-chain expression by transforming growth factor-beta involves transactivation by Smads.

Authors:  L M Taylor; L M Khachigian
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

3.  The YXXL motif, but not the two NPXY motifs, serves as the dominant endocytosis signal for low density lipoprotein receptor-related protein.

Authors:  Y Li; M P Marzolo; P van Kerkhof; G J Strous; G Bu
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

4.  Subcellular localization and endocytic function of low density lipoprotein receptor-related protein in human glioblastoma cells.

Authors:  G Bu; E A Maksymovitch; H Geuze; A L Schwartz
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

5.  Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation.

Authors:  Patricia G Yancey; John Blakemore; Lei Ding; Daping Fan; Cheryl D Overton; Youmin Zhang; MacRae F Linton; Sergio Fazio
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-11       Impact factor: 8.311

6.  Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein.

Authors:  M Trommsdorff; J P Borg; B Margolis; J Herz
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

7.  Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice.

Authors:  Petra May; Astrid Rohlmann; Hans H Bock; Kai Zurhove; Jamey D Marth; Eike D Schomburg; Jeffrey L Noebels; Uwe Beffert; J David Sweatt; Edwin J Weeber; Joachim Herz
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

8.  LRP and alphavbeta3 mediate tPA activation of smooth muscle cells.

Authors:  Sa'ed Akkawi; Taher Nassar; Mark Tarshis; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-02-17       Impact factor: 4.733

9.  Gamma-secretase limits the inflammatory response through the processing of LRP1.

Authors:  Kai Zurhove; Chikako Nakajima; Joachim Herz; Hans H Bock; Petra May
Journal:  Sci Signal       Date:  2008-11-25       Impact factor: 8.192

10.  Generation of the beta-amyloid peptide and the amyloid precursor protein C-terminal fragment gamma are potentiated by FE65L1.

Authors:  Yang Chang; Giuseppina Tesco; William J Jeong; Loren Lindsley; Elizabeth A Eckman; Christopher B Eckman; Rudolph E Tanzi; Suzanne Y Guénette
Journal:  J Biol Chem       Date:  2003-10-03       Impact factor: 5.157

View more
  45 in total

1.  Low-Density Lipoprotein Receptor-Related Protein-1 (LRP1) C4408R Mutant Promotes Amyloid Precursor Protein (APP) α-Cleavage in Vitro.

Authors:  Huayan Hou; Ahsan Habib; Dan Zi; Kathy Tian; Jun Tian; Brian Giunta; Darrell Sawmiller; Jun Tan
Journal:  Neuromolecular Med       Date:  2017-06-13       Impact factor: 3.843

Review 2.  Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.

Authors:  Abhay P Sagare; Rashid Deane; Berislav V Zlokovic
Journal:  Pharmacol Ther       Date:  2012-07-20       Impact factor: 12.310

3.  High Affinity Binding of the Receptor-associated Protein D1D2 Domains with the Low Density Lipoprotein Receptor-related Protein (LRP1) Involves Bivalent Complex Formation: CRITICAL ROLES OF LYSINES 60 AND 191.

Authors:  Joni M Prasad; Patricia A Young; Dudley K Strickland
Journal:  J Biol Chem       Date:  2016-07-11       Impact factor: 5.157

4.  Increased expression of LDL receptor-related protein 1 during human cytomegalovirus infection reduces virion cholesterol and infectivity.

Authors:  Nicole Gudleski-O'Regan; Todd M Greco; Ileana M Cristea; Thomas Shenk
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

5.  Low-density lipoprotein receptor-related protein 1 attenuates house dust mite-induced eosinophilic airway inflammation by suppressing dendritic cell-mediated adaptive immune responses.

Authors:  Amarjit Mishra; Xianglan Yao; Ankit Saxena; Elizabeth M Gordon; Maryann Kaler; Rosemarie A Cuento; Amisha V Barochia; Pradeep K Dagur; J Philip McCoy; Karen J Keeran; Kenneth R Jeffries; Xuan Qu; Zu-Xi Yu; Stewart J Levine
Journal:  J Allergy Clin Immunol       Date:  2017-12-21       Impact factor: 10.793

6.  The Role of Efferocytosis in Atherosclerosis.

Authors:  Yoko Kojima; Irving L Weissman; Nicholas J Leeper
Journal:  Circulation       Date:  2017-01-31       Impact factor: 29.690

7.  LRP1-Dependent BMPER Signaling Regulates Lipopolysaccharide-Induced Vascular Inflammation.

Authors:  Pamela Lockyer; Hua Mao; Qiying Fan; Luge Li; Li-Yuan Yu-Lee; N Tony Eissa; Cam Patterson; Liang Xie; Xinchun Pi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-08       Impact factor: 8.311

8.  ApoER2 (Apolipoprotein E Receptor-2) Deficiency Accelerates Smooth Muscle Cell Senescence via Cytokinesis Impairment and Promotes Fibrotic Neointima After Vascular Injury.

Authors:  Ravi K Komaravolu; Meaghan D Waltmann; Eddy Konaniah; Anja Jaeschke; David Y Hui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-15       Impact factor: 8.311

9.  The P2Y2 receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells.

Authors:  Tixieanna Dissmore; Cheikh I Seye; Denis M Medeiros; Gary A Weisman; Barry Bradford; Laman Mamedova
Journal:  Atherosclerosis       Date:  2016-07-29       Impact factor: 5.162

10.  Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.

Authors:  Lin Zhu; Ilaria Giunzioni; Hagai Tavori; Roman Covarrubias; Lei Ding; Youmin Zhang; Michelle Ormseth; Amy S Major; John M Stafford; MacRae F Linton; Sergio Fazio
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-06-30       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.